Patent Sequence Listing

ST.25 vs ST.26: A Comparative Analysis of Patent Sequence Listing Standards  

The world of intellectual property is vast and complex. Various standards and guidelines ensure to document these inventions and innovations correctly. Specifically, in the realm of biotechnology and genetic engineering, patent sequence listings play a crucial role in applications as they provide a detailed representation of the nucleotide and amino acid sequences that make up[…]

The Art of ST26 Sequence Listing Preparation Best Practices for Accuracy and Compliance

The Art of ST.26 Sequence Listing Preparation: Best Practices for Accuracy and Compliance

Sequence listings are an essential part of biotech patent applications. They list nucleotide and/or amino acid sequences associated with the invention. These sequence listings assist patent offices in evaluating the novelty and non-obviousness of inventions. Thus, their accuracy, completeness, and compliance with the latest sequence listing standard are critical to the success of the patent[…]

What is new in WIPO’s ST26 Sequence Listing Standard

What is New in WIPO’s ST.26 Sequence Listing Standard

All patent applications specifying nucleotide or amino acid sequences must include a sequence listing. The World Intellectual Property Organization (WIPO) has set forth international standards for preparing sequence listings, and failure to comply with these guidelines may result in the rejection of the patent application. WIPO recently introduced the latest sequence listing standard, ST26, which[…]